Analysis of medication law of treatment of cholelithiasis by internal traditional Chinese medicine based on traditional Chinese medicine inheritance system

摘要

Objective:Based on the Traditional Chinese Medicine Inheritance System version 2.5 to explore the rule of medication used in internal traditional Chinese medicine for cholelithiasis in the national patent network.Method:Collect the internal administrations of cholelithiasis in the national patent network,and enter them into the Chinese medicine inheritance system version 2.5,adopt frequency analysis,association rules,complex system entropy clustering and other data mining methods to analyze the prescription rule of traditional Chinese medicine cholelithiasis.Results:According to the inclusion and exclusion criteria,215 prescriptions were selected,involving 398 drugs,30 drugs with a frequency of>20,and 39 commonly used drug pairs.The core drugs are:Jinqiancao(Herba Lysimachiae),Yujin(Radix Curcumae),Chaihu(Radix Bupleuri),Yinchen(Herba Artemisiae Scopariae),Jineijin(Endothelium Corneum Gigeriae Galli),Dahuang(Radix et Rhizoma Rhei),Gancao(Radix Glycyrrhizae),Huangqin(Radix Scutellariae),Baishao(Raidix Paeoniae Alba),Muxiang(Radix Aucklandiae),Zhishi(Fructus Aurantii Immaturus),Yanhusuo(Rhizoma Corydalis),Huzhang(Rhizoma Polygoni Cuspidati),Haijinsha(Herba Lygodii).And 9 new prescriptions have been got.Conclusion:In the national patent network,the traditional Chinese medicine is used in the treatment of cholelithiasis.The main treatment is clearing heat and dampness,regulating Qi and relieving pain,and promoting gallbladder removing stone,providing reference for clinical treatment of cholelithiasis.